外骨骼辅助行走改善脊髓损伤患者肺功能与步行参数:随机对照预试验
这项前瞻性单中心单盲随机对照预试验将18例脊髓损伤患者分为外骨骼辅助行走组(n=9)和常规训练组(n=9),各接受16次、每次50-60分钟、每周4天共4周的训练。结果显示外骨骼组训练后FVC、FVC占预计值百分比和FEV1显著优于常规组,外骨骼组穿戴外骨骼完成6分钟步行试验中位距离17.3米,两组下肢运动评分无差异且无不良事件。
要点
- 外骨骼辅助行走训练后FVC、FVC占预计值百分比和FEV1显著优于常规训练组。
- 外骨骼组穿戴外骨骼完成6分钟步行试验的中位距离为17.3米。
- 两组下肢运动评分无差异,训练期间无不良事件报告。
核心结论
- 外骨骼辅助行走相比常规训练可能有助于改善下胸段脊髓损伤患者的肺功能参数。
- 机器人外骨骼可辅助脊髓损伤患者完成步行训练。
研究设计与样本
- 前瞻性、单中心、单盲随机对照预试验,共纳入18例脊髓损伤患者。
- 参与者随机分为外骨骼辅助行走组(n=9)和常规训练组(n=9)。
- 两组均接受16次训练,每次50-60分钟,每周4天,共4周。
- 训练前后评估肺功能参数、辅助器具下6分钟步行试验和下肢运动评分。
主要发现
- 训练后外骨骼组FVC为3.8±1.1 L,常规组为2.8±0.8 L,组间差异p=0.041。
- 训练后外骨骼组FVC占预计值百分比为94.1±24.5%,常规组为65.4±17.6%,组间差异p=0.012。
- 训练后外骨骼组FEV1为3.5±1.0 L,常规组为2.4±0.6 L,组间差异p=0.013。
- 外骨骼组穿戴外骨骼完成6分钟步行试验的中位距离为17.3米。
- 两组下肢运动评分无差异,且无不良事件报告。
关键数值与推荐
- 外骨骼辅助行走组训练后FVC、FVC占预计值百分比和FEV1显著高于常规训练组(p值分别为0.041、0.012、0.013)。
- 外骨骼组穿戴外骨骼完成6分钟步行试验的中位距离为17.3米。
- 两组下肢运动评分无差异,无不良事件。
临床怎么用
- 对下胸段脊髓损伤患者,可考虑采用外骨骼辅助行走训练以改善肺功能参数。
- 外骨骼辅助行走训练方案为每次50-60分钟、每周4天、共4周、总计16次。
- 训练期间未报告不良事件,但需注意本研究为预试验,结果需进一步验证。
局限性
- 本研究为预试验,样本量较小(共18例)。
- 单中心、单盲设计可能影响结果外推。
- 结论主要针对下胸段神经平面脊髓损伤患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Exoskeleton-assisted walking (EAW) is expected to improve the gait of spinal cord injury (SCI) individuals. However, few studies reported the changes of pulmonary function (PF) parameters after EAW trainings. Hence, we aimed to explore the effect of EAW on PF parameters, 6-min walk test (6MWT) and lower extremity motor score (LEMS) in individuals with SCI and to compare those with conventional trainings. METHODS: In this prospective, single-center, single-blinded randomized controlled pilot study, 18 SCI participants were randomized into the EAW group (n = 9) and conventional group (n = 9) and received 16 sessions of 50-60 min training (4 days/week, 4 weeks). Pulmonary function parameters consisting of the forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), forced expiratory flow (FEF), peak expiratory flow, and maximal voluntary ventilation, 6MWT with assisted devices and LEMS were reported pre- and post-training. RESULTS: Values of FVC (p = 0.041), predicted FVC% (p = 0.012) and FEV1 (p = 0.013) were significantly greater in EAW group (FVC: 3.8 ± 1.1 L; FVC% pred = 94.1 ± 24.5%; FEV1: 3.5 ± 1.0 L) compared with conventional group (FVC: 2.8 ± 0.8 L; FVC% pred = 65.4 ± 17.6%; FEV1: 2.4 ± 0.6 L) after training. Participants in EAW group completed 6MWT with median 17.3 m while wearing the exoskeleton. There was no difference in LEMS and no adverse event. CONCLUSIONS: The current results suggest that EAW has potential benefits to facilitate PF parameters among individuals with lower thoracic neurological level of SCI compared with conventional trainings. Additionally, robotic exoskeleton helped walking. TRIAL REGISTRATION: Registered on 22 May 2020 at Chinese Clinical Trial Registry (ChiCTR2000033166). http://www.chictr.org.cn/edit.aspx?pid=53920&htm=4 .
引用
- Xiang XN, Zong HY, Ou Y, et al. Exoskeleton-assisted walking improves pulmonary function and walking parameters among individuals with spinal cord injury: a randomized controlled pilot study. J Neuroeng Rehabil. 2021. PMID: 34030720. doi:10.1186/s12984-021-00880-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。